Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting

KRAS is commonly mutated at codon 12 in several cancer types, offering a unique opportunity for the development of neoantigen-targeted immunotherapy. Here the authors present a pipeline for the prediction, identification and validation of HLA class-I restricted mutant KRAS G12 peptides, leading to t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Adham S. Bear, Tatiana Blanchard, Joseph Cesare, Michael J. Ford, Lee P. Richman, Chong Xu, Miren L. Baroja, Sarah McCuaig, Christina Costeas, Khatuna Gabunia, John Scholler, Avery D. Posey, Mark H. O’Hara, Anze Smole, Daniel J. Powell, Benjamin A. Garcia, Robert H. Vonderheide, Gerald P. Linette, Beatriz M. Carreno
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/5c32458bd77b40989a4cd89c57021223
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5c32458bd77b40989a4cd89c57021223
record_format dspace
spelling oai:doaj.org-article:5c32458bd77b40989a4cd89c570212232021-12-02T18:36:59ZBiochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting10.1038/s41467-021-24562-22041-1723https://doaj.org/article/5c32458bd77b40989a4cd89c570212232021-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24562-2https://doaj.org/toc/2041-1723KRAS is commonly mutated at codon 12 in several cancer types, offering a unique opportunity for the development of neoantigen-targeted immunotherapy. Here the authors present a pipeline for the prediction, identification and validation of HLA class-I restricted mutant KRAS G12 peptides, leading to the generation of mutant KRAS-specific T cell receptors for adoptive T cell immunotherapy.Adham S. BearTatiana BlanchardJoseph CesareMichael J. FordLee P. RichmanChong XuMiren L. BarojaSarah McCuaigChristina CosteasKhatuna GabuniaJohn SchollerAvery D. PoseyMark H. O’HaraAnze SmoleDaniel J. PowellBenjamin A. GarciaRobert H. VonderheideGerald P. LinetteBeatriz M. CarrenoNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Adham S. Bear
Tatiana Blanchard
Joseph Cesare
Michael J. Ford
Lee P. Richman
Chong Xu
Miren L. Baroja
Sarah McCuaig
Christina Costeas
Khatuna Gabunia
John Scholler
Avery D. Posey
Mark H. O’Hara
Anze Smole
Daniel J. Powell
Benjamin A. Garcia
Robert H. Vonderheide
Gerald P. Linette
Beatriz M. Carreno
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
description KRAS is commonly mutated at codon 12 in several cancer types, offering a unique opportunity for the development of neoantigen-targeted immunotherapy. Here the authors present a pipeline for the prediction, identification and validation of HLA class-I restricted mutant KRAS G12 peptides, leading to the generation of mutant KRAS-specific T cell receptors for adoptive T cell immunotherapy.
format article
author Adham S. Bear
Tatiana Blanchard
Joseph Cesare
Michael J. Ford
Lee P. Richman
Chong Xu
Miren L. Baroja
Sarah McCuaig
Christina Costeas
Khatuna Gabunia
John Scholler
Avery D. Posey
Mark H. O’Hara
Anze Smole
Daniel J. Powell
Benjamin A. Garcia
Robert H. Vonderheide
Gerald P. Linette
Beatriz M. Carreno
author_facet Adham S. Bear
Tatiana Blanchard
Joseph Cesare
Michael J. Ford
Lee P. Richman
Chong Xu
Miren L. Baroja
Sarah McCuaig
Christina Costeas
Khatuna Gabunia
John Scholler
Avery D. Posey
Mark H. O’Hara
Anze Smole
Daniel J. Powell
Benjamin A. Garcia
Robert H. Vonderheide
Gerald P. Linette
Beatriz M. Carreno
author_sort Adham S. Bear
title Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
title_short Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
title_full Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
title_fullStr Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
title_full_unstemmed Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
title_sort biochemical and functional characterization of mutant kras epitopes validates this oncoprotein for immunological targeting
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5c32458bd77b40989a4cd89c57021223
work_keys_str_mv AT adhamsbear biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT tatianablanchard biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT josephcesare biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT michaeljford biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT leeprichman biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT chongxu biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT mirenlbaroja biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT sarahmccuaig biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT christinacosteas biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT khatunagabunia biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT johnscholler biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT averydposey biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT markhohara biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT anzesmole biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT danieljpowell biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT benjaminagarcia biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT roberthvonderheide biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT geraldplinette biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
AT beatrizmcarreno biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting
_version_ 1718377861959647232